2024 ICD-10-CM Diagnosis Code Q79.69

Other Ehlers-Danlos syndromes

ICD-10-CM Code:
Q79.69
ICD-10 Code for:
Other Ehlers-Danlos syndromes
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Chronic
Code Navigator:

Code Classification

  • Congenital malformations, deformations and chromosomal abnormalities
    (Q00-Q99)
    • Congenital malformations and deformations of the musculoskeletal system
      (Q65-Q79)
      • Congenital malformations of musculoskeletal system, not elsewhere classified
        (Q79)

Q79.69 is a billable diagnosis code used to specify a medical diagnosis of other ehlers-danlos syndromes. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome
  • Brittle cornea syndrome
  • Classical-like Ehlers-Danlos syndrome type 2
  • Congenital kyphoscoliosis
  • Congenital kyphoscoliosis
  • Congenital kyphoscoliosis
  • Congenital kyphosis
  • Congenital kyphosis
  • Congenital kyphosis
  • Corneal thinning
  • Cutis laxa, x-linked
  • Dermatosparaxis Ehlers-Danlos syndrome
  • Disorder of copper metabolism
  • Ehlers-Danlos syndrome cardiac valvular type
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
  • Ehlers-Danlos syndrome kyphoscoliotic and deafness type
  • Ehlers-Danlos syndrome kyphoscoliotic type
  • Ehlers-Danlos syndrome kyphoscoliotic type
  • Ehlers-Danlos syndrome musculocontractural type
  • Ehlers-Danlos syndrome progeroid type
  • Ehlers-Danlos syndrome spondylocheirodysplastic type
  • Ehlers-Danlos syndrome, dysfibronectinemic
  • Ehlers-Danlos syndrome, familial joint laxity type
  • Ehlers-Danlos syndrome, hydroxylysine-deficient
  • Ehlers-Danlos syndrome, non hydroxylysine deficient ocular type
  • Ehlers-Danlos syndrome, procollagen proteinase deficient
  • Ehlers-Danlos syndrome, procollagen proteinase resistant
  • Ehlers-Danlos syndrome, type 5
  • Ehlers-Danlos syndrome, type 8
  • Myopathic Ehlers-Danlos syndrome
  • Periodontitis co-occurrent with genetic disorder
  • Spondylodysplastic Ehlers-Danlos syndrome

Clinical Classification

Clinical Information

  • Corneal Thinning

    progressive deformation of the corneal structure, characterized by thinning of the cornea.
  • Congenital Kyphosis

    an abnormally increased curvature of the thoracic portion of the spine that is present at the time of birth.

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Present on Admission (POA)

Q79.69 is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.

CMS POA Indicator Options and Definitions

POA IndicatorReason for CodeCMS will pay the CC/MCC DRG?
YDiagnosis was present at time of inpatient admission.YES
NDiagnosis was not present at time of inpatient admission.NO
UDocumentation insufficient to determine if the condition was present at the time of inpatient admission.NO
WClinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission.YES
1Unreported/Not used - Exempt from POA reporting. NO

Replacement Code

Q7969 replaces the following previously assigned ICD-10-CM code(s):

  • Q79.6 - Ehlers-Danlos syndrome
  • Q79.6 - Ehlers-Danlos syndromes

Patient Education


Ehlers-Danlos Syndrome

Ehlers-Danlos syndrome (EDS) is a group of inherited disorders that weaken connective tissues. Connective tissues are proteins that support skin, bones, blood vessels, and other organs.

EDS usually affects your skin, joints and blood vessel walls. Symptoms include:

  • Loose joints
  • Fragile, small blood vessels
  • Abnormal scar formation and wound healing
  • Soft, velvety, stretchy skin that bruises easily

There are several types of EDS. They can range from mild to life-threatening. About 1 in 5,000 people has EDS. There is no cure. Treatment involves managing symptoms, often with medicines and physical therapy. It also includes learning how to protect your joints and prevent injuries.


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.